Lake Street Advisors Group LLC bought a new stake in Monsanto (NYSE:MON) in the fourth quarter, HoldingsChannel reports. The fund bought 1,930 shares of the basic materials company’s stock, valued at approximately $225,000.
A number of other institutional investors and hedge funds also recently made changes to their positions in the stock. Gradient Investments LLC acquired a new stake in Monsanto in the 4th quarter valued at about $108,000. Americafirst Capital Management LLC acquired a new stake in Monsanto in the 3rd quarter valued at about $148,000. Elkfork Partners LLC acquired a new stake in Monsanto in the 4th quarter valued at about $162,000. Truewealth LLC acquired a new stake in Monsanto in the 4th quarter valued at about $163,000. Finally, Flinton Capital Management LLC lifted its holdings in Monsanto by 90.9% in the 4th quarter. Flinton Capital Management LLC now owns 1,764 shares of the basic materials company’s stock valued at $206,000 after acquiring an additional 840 shares during the last quarter. Hedge funds and other institutional investors own 76.21% of the company’s stock.
Shares of Monsanto stock opened at $117.15 on Friday. The company has a debt-to-equity ratio of 1.05, a quick ratio of 0.79 and a current ratio of 1.28. Monsanto has a 52 week low of $113.09 and a 52 week high of $124.20. The company has a market cap of $51,639.84, a PE ratio of 21.61, a price-to-earnings-growth ratio of 1.69 and a beta of 0.95.
The company also recently disclosed a quarterly dividend, which will be paid on Friday, April 27th. Shareholders of record on Friday, April 6th will be paid a dividend of $0.54 per share. This represents a $2.16 dividend on an annualized basis and a yield of 1.84%. The ex-dividend date is Thursday, April 5th. Monsanto’s dividend payout ratio is presently 39.85%.
In other Monsanto news, EVP Steven Mizell sold 8,100 shares of the company’s stock in a transaction dated Tuesday, January 9th. The shares were sold at an average price of $119.35, for a total transaction of $966,735.00. Following the completion of the sale, the executive vice president now directly owns 56,743 shares of the company’s stock, valued at $6,772,277.05. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. 0.79% of the stock is currently owned by corporate insiders.
MON has been the subject of a number of research analyst reports. Zacks Investment Research downgraded shares of Monsanto from a “buy” rating to a “hold” rating in a report on Monday, December 11th. Deutsche Bank reissued a “buy” rating on shares of Monsanto in a report on Tuesday, January 16th. Finally, Wells Fargo reissued a “market perform” rating and issued a $128.00 price target (up from $118.00) on shares of Monsanto in a report on Wednesday, January 17th. Eleven investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and a consensus target price of $127.30.
TRADEMARK VIOLATION WARNING: This news story was posted by Ticker Report and is the sole property of of Ticker Report. If you are viewing this news story on another site, it was copied illegally and republished in violation of US and international trademark & copyright law. The original version of this news story can be viewed at https://www.tickerreport.com/banking-finance/3299008/1930-shares-in-monsanto-mon-purchased-by-lake-street-advisors-group-llc.html.
Monsanto Company Profile
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Want to see what other hedge funds are holding MON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Monsanto (NYSE:MON).
Receive News & Ratings for Monsanto Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto and related companies with MarketBeat.com's FREE daily email newsletter.